REPORTS

Let’s Pullulate and Expand Your Business

Global T-Cell Immunotherapy Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Oct 16, 2019  |  153 PAGES  |  REPORT CODE: CMM213685
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The T-Cell Immunotherapy is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period. The research provides insights for the global T-Cell Immunotherapy market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the T-Cell Immunotherapy industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global T-Cell Immunotherapy Market Segmentations:

By Players:

  • Juno Therapeutics

  • Takara Bio

  • Kite Pharma

  • Biotecnol

  • Unum Therapeutics

  • Altor Bioscience Corporation

  • Novartis

  • Cellectis

  • Adaptimmune

By Types:

  • CAR-T

  • TCR

  • TIL Therapies

By End-User:

  • Stomach Cancer

  • Lung Cancer

  • Colorectal Cancer

  • Esophagus Cancer

  • Pancreatic Cancer

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of T-Cell Immunotherapy Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global T-Cell Immunotherapy Market Share by Types

    • 1.3.2 Global T-Cell Immunotherapy Market Size and Growth Rate of CAR-T from 2014 to 2026

    • 1.3.3 Global T-Cell Immunotherapy Market Size and Growth Rate of TCR from 2014 to 2026

    • 1.3.4 Global T-Cell Immunotherapy Market Size and Growth Rate of TIL Therapies from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global T-Cell Immunotherapy Market Share by End-Users

    • 1.4.2 Global T-Cell Immunotherapy Market Size and Growth Rate of Stomach Cancer from 2014 to 2026

    • 1.4.3 Global T-Cell Immunotherapy Market Size and Growth Rate of Lung Cancer from 2014 to 2026

    • 1.4.4 Global T-Cell Immunotherapy Market Size and Growth Rate of Colorectal Cancer from 2014 to 2026

    • 1.4.5 Global T-Cell Immunotherapy Market Size and Growth Rate of Esophagus Cancer from 2014 to 2026

    • 1.4.6 Global T-Cell Immunotherapy Market Size and Growth Rate of Pancreatic Cancer from 2014 to 2026

    • 1.4.7 Global T-Cell Immunotherapy Market Size and Growth Rate of Others from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of T-Cell Immunotherapy Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of T-Cell Immunotherapy by Major Types

    • 3.4.1 Market Size and Growth Rate of CAR-T

    • 3.4.2 Market Size and Growth Rate of TCR

    • 3.4.3 Market Size and Growth Rate of TIL Therapies

4 Segmentation of T-Cell Immunotherapy Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of T-Cell Immunotherapy by Major End-Users

    • 4.4.1 Market Size and Growth Rate of T-Cell Immunotherapy for Stomach Cancer

    • 4.4.2 Market Size and Growth Rate of T-Cell Immunotherapy for Lung Cancer

    • 4.4.3 Market Size and Growth Rate of T-Cell Immunotherapy for Colorectal Cancer

    • 4.4.4 Market Size and Growth Rate of T-Cell Immunotherapy for Esophagus Cancer

    • 4.4.5 Market Size and Growth Rate of T-Cell Immunotherapy for Pancreatic Cancer

    • 4.4.6 Market Size and Growth Rate of T-Cell Immunotherapy for Others

5 Market Analysis by Major Regions

  • 5.1 Global T-Cell Immunotherapy Production Analysis by Major Regions

  • 5.2 Global T-Cell Immunotherapy Consumption Analysis by Major Regions

  • 5.3 Global T-Cell Immunotherapy Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America T-Cell Immunotherapy Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

6 Product Commodity of T-Cell Immunotherapy Market in Major Countries

  • 6.1 Top 5 Export Countries in T-Cell Immunotherapy market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in T-Cell Immunotherapy market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in T-Cell Immunotherapy market from 2014 to 2019

  • 6.2 Top 5 Import Countries in T-Cell Immunotherapy market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in T-Cell Immunotherapy market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in T-Cell Immunotherapy market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America T-Cell Immunotherapy Landscape Analysis

  • 7.1 North America T-Cell Immunotherapy Landscape Analysis by Major Types

  • 7.2 North America T-Cell Immunotherapy Landscape Analysis by Major End-Users

  • 7.3 North America T-Cell Immunotherapy Landscape Analysis by Major Countries

    • 7.3.1 United States T-Cell Immunotherapy Market Volume and Growth Rate

    • 7.3.2 Canada T-Cell Immunotherapy Market Volume and Growth Rate

    • 7.3.3 Mexico T-Cell Immunotherapy Market Volume and Growth Rate

8 Europe T-Cell Immunotherapy Landscape Analysis

  • 8.1 Europe T-Cell Immunotherapy Landscape Analysis by Major Types

  • 8.2 Europe T-Cell Immunotherapy Landscape Analysis by Major End-Users

  • 8.3 Europe T-Cell Immunotherapy Landscape Analysis by Major Countries

    • 8.3.1 Germany T-Cell Immunotherapy Market Volume and Growth Rate

    • 8.3.2 UK T-Cell Immunotherapy Market Volume and Growth Rate

    • 8.3.3 France T-Cell Immunotherapy Market Volume and Growth Rate

    • 8.3.4 Italy T-Cell Immunotherapy Market Volume and Growth Rate

    • 8.3.5 Nordic Countries T-Cell Immunotherapy Market Volume and Growth Rate

    • 8.3.6 Spain T-Cell Immunotherapy Market Volume and Growth Rate

    • 8.3.7 Belgium T-Cell Immunotherapy Market Volume and Growth Rate

    • 8.3.8 Poland T-Cell Immunotherapy Market Volume and Growth Rate

    • 8.3.9 Russia T-Cell Immunotherapy Market Volume and Growth Rate

    • 8.3.10 Turkey T-Cell Immunotherapy Market Volume and Growth Rate

9 Asia Pacific T-Cell Immunotherapy Landscape Analysis

  • 9.1 Asia Pacific T-Cell Immunotherapy Landscape Analysis by Major Types

  • 9.2 Asia Pacific T-Cell Immunotherapy Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific T-Cell Immunotherapy Landscape Analysis by Major Countries

    • 9.3.1 China T-Cell Immunotherapy Market Volume and Growth Rate

    • 9.3.2 Japan T-Cell Immunotherapy Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand T-Cell Immunotherapy Market Volume and Growth Rate

    • 9.3.4 India T-Cell Immunotherapy Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries T-Cell Immunotherapy Market Volume and Growth Rate

    • 9.3.6 South Korea T-Cell Immunotherapy Market Volume and Growth Rate

10 Latin America, Middle East & Africa T-Cell Immunotherapy Landscape Analysis

  • 10.1 Latin America, Middle East & Africa T-Cell Immunotherapy Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa T-Cell Immunotherapy Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa T-Cell Immunotherapy Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries T-Cell Immunotherapy Market Volume and Growth Rate

    • 10.3.2 Brazil T-Cell Immunotherapy Market Volume and Growth Rate

    • 10.3.3 Nigeria T-Cell Immunotherapy Market Volume and Growth Rate

    • 10.3.4 South Africa T-Cell Immunotherapy Market Volume and Growth Rate 

    • 10.3.5 Argentina T-Cell Immunotherapy Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Juno Therapeutics

    • 11.1.1 Juno Therapeutics Company Profile and Development Status

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Takara Bio

    • 11.2.1 Takara Bio Company Profile and Development Status

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Kite Pharma

    • 11.3.1 Kite Pharma Company Profile and Development Status

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Biotecnol

    • 11.4.1 Biotecnol Company Profile and Development Status

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Unum Therapeutics

    • 11.5.1 Unum Therapeutics Company Profile and Development Status

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Altor Bioscience Corporation

    • 11.6.1 Altor Bioscience Corporation Company Profile and Development Status

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Novartis

    • 11.7.1 Novartis Company Profile and Development Status

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Cellectis

    • 11.8.1 Cellectis Company Profile and Development Status

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Adaptimmune

    • 11.9.1 Adaptimmune Company Profile and Development Status

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 102 Figures and 132 Tables)

  • Figure Product Picture

  • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of CAR-T from 2014 to 2026

  • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of TCR from 2014 to 2026

  • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of TIL Therapies from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Stomach Cancer from 2014 to 2026

  • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Lung Cancer from 2014 to 2026

  • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Colorectal Cancer from 2014 to 2026

  • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Esophagus Cancer from 2014 to 2026

  • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Pancreatic Cancer from 2014 to 2026

  • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of T-Cell Immunotherapy Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of T-Cell Immunotherapy

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of T-Cell Immunotherapy by Different Types from 2014 to 2026

  • Table Consumption Share of T-Cell Immunotherapy by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of CAR-T

  • Figure Market Size and Growth Rate of TCR

  • Figure Market Size and Growth Rate of TIL Therapies

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of T-Cell Immunotherapy by Different End-Users from 2014 to 2026

  • Table Consumption Share of T-Cell Immunotherapy by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Stomach Cancer

  • Figure Market Size and Growth Rate of Lung Cancer

  • Figure Market Size and Growth Rate of Colorectal Cancer

  • Figure Market Size and Growth Rate of Esophagus Cancer

  • Figure Market Size and Growth Rate of Pancreatic Cancer

  • Figure Market Size and Growth Rate of Others

  • Table Global T-Cell Immunotherapy Production by Major Regions

  • Table Global T-Cell Immunotherapy Production Share by Major Regions

  • Figure Global T-Cell Immunotherapy Production Share by Major Regions in 2014

  • Figure Global T-Cell Immunotherapy Production Share by Major Regions in 2018

  • Figure Global T-Cell Immunotherapy Production Share by Major Regions in 2026

  • Table Global T-Cell Immunotherapy Consumption by Major Regions

  • Table Global T-Cell Immunotherapy Consumption Share by Major Regions

  • Figure Global T-Cell Immunotherapy Consumption Share by Major Regions in 2014

  • Figure Global T-Cell Immunotherapy Consumption Share by Major Regions in 2018

  • Figure Global T-Cell Immunotherapy Consumption Share by Major Regions in 2026

  • Table North America T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

  • Table Europe T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

  • Table Asia Pacific T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in T-Cell Immunotherapy market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in T-Cell Immunotherapy market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in T-Cell Immunotherapy market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in T-Cell Immunotherapy market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America T-Cell Immunotherapy Consumption by Types from 2014 to 2026

  • Table North America T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

  • Figure North America T-Cell Immunotherapy Consumption Share by Types in 2014

  • Figure North America T-Cell Immunotherapy Consumption Share by Types in 2018

  • Figure North America T-Cell Immunotherapy Consumption Share by Types in 2026

  • Table North America T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

  • Table North America T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

  • Figure North America T-Cell Immunotherapy Consumption Share by End-Users in 2014

  • Figure North America T-Cell Immunotherapy Consumption Share by End-Users in 2018

  • Figure North America T-Cell Immunotherapy Consumption Share by End-Users in 2026

  • Table North America T-Cell Immunotherapy Consumption by Major Countries from 2014 to 2026

  • Table North America T-Cell Immunotherapy Consumption Share by Major Countries from 2014 to 2026

  • Figure North America T-Cell Immunotherapy Consumption Share by Major Countries in 2014

  • Figure North America T-Cell Immunotherapy Consumption Share by Major Countries in 2018

  • Figure North America T-Cell Immunotherapy Consumption Share by Major Countries in 2026

  • Figure United States T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Table Europe T-Cell Immunotherapy Consumption by Types from 2014 to 2026

  • Table Europe T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

  • Figure Europe T-Cell Immunotherapy Consumption Share by Types in 2014

  • Figure Europe T-Cell Immunotherapy Consumption Share by Types in 2018

  • Figure Europe T-Cell Immunotherapy Consumption Share by Types in 2026

  • Table Europe T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

  • Table Europe T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

  • Figure Europe T-Cell Immunotherapy Consumption Share by End-Users in 2014

  • Figure Europe T-Cell Immunotherapy Consumption Share by End-Users in 2018

  • Figure Europe T-Cell Immunotherapy Consumption Share by End-Users in 2026

  • Table Europe T-Cell Immunotherapy Consumption by Major Countries from 2014 to 2026

  • Table Europe T-Cell Immunotherapy Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe T-Cell Immunotherapy Consumption Share by Major Countries in 2014

  • Figure Europe T-Cell Immunotherapy Consumption Share by Major Countries in 2018

  • Figure Europe T-Cell Immunotherapy Consumption Share by Major Countries in 2026

  • Figure Germany T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure UK T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure France T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific T-Cell Immunotherapy Consumption by Types from 2014 to 2026

  • Table Asia Pacific T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific T-Cell Immunotherapy Consumption Share by Types in 2014

  • Figure Asia Pacific T-Cell Immunotherapy Consumption Share by Types in 2018

  • Figure Asia Pacific T-Cell Immunotherapy Consumption Share by Types in 2026

  • Table Asia Pacific T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific T-Cell Immunotherapy Consumption Share by End-Users in 2014

  • Figure Asia Pacific T-Cell Immunotherapy Consumption Share by End-Users in 2018

  • Figure Asia Pacific T-Cell Immunotherapy Consumption Share by End-Users in 2026

  • Table Asia Pacific T-Cell Immunotherapy Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific T-Cell Immunotherapy Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific T-Cell Immunotherapy Consumption Share by Major Countries in 2014

  • Figure Asia Pacific T-Cell Immunotherapy Consumption Share by Major Countries in 2018

  • Figure Asia Pacific T-Cell Immunotherapy Consumption Share by Major Countries in 2026

  • Figure China T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandT-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure India T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa T-Cell Immunotherapy Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa T-Cell Immunotherapy Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa T-Cell Immunotherapy Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa T-Cell Immunotherapy Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa T-Cell Immunotherapy Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa T-Cell Immunotherapy Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa T-Cell Immunotherapy Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa T-Cell Immunotherapy Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa T-Cell Immunotherapy Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa T-Cell Immunotherapy Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa T-Cell Immunotherapy Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa T-Cell Immunotherapy Consumption Share by Major Countries in 2026

  • Figure GCC Countries T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Juno Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics

  • Figure Sales and Growth Rate Analysis of Juno Therapeutics

  • Figure Revenue and Market Share Analysis of Juno Therapeutics

  • Table Product and Service Introduction of Juno Therapeutics

  • Table Company Profile and Development Status of Takara Bio

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takara Bio

  • Figure Sales and Growth Rate Analysis of Takara Bio

  • Figure Revenue and Market Share Analysis of Takara Bio

  • Table Product and Service Introduction of Takara Bio

  • Table Company Profile and Development Status of Kite Pharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma

  • Figure Sales and Growth Rate Analysis of Kite Pharma

  • Figure Revenue and Market Share Analysis of Kite Pharma

  • Table Product and Service Introduction of Kite Pharma

  • Table Company Profile and Development Status of Biotecnol

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotecnol

  • Figure Sales and Growth Rate Analysis of Biotecnol

  • Figure Revenue and Market Share Analysis of Biotecnol

  • Table Product and Service Introduction of Biotecnol

  • Table Company Profile and Development Status of Unum Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Unum Therapeutics

  • Figure Sales and Growth Rate Analysis of Unum Therapeutics

  • Figure Revenue and Market Share Analysis of Unum Therapeutics

  • Table Product and Service Introduction of Unum Therapeutics

  • Table Company Profile and Development Status of Altor Bioscience Corporation

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altor Bioscience Corporation

  • Figure Sales and Growth Rate Analysis of Altor Bioscience Corporation

  • Figure Revenue and Market Share Analysis of Altor Bioscience Corporation

  • Table Product and Service Introduction of Altor Bioscience Corporation

  • Table Company Profile and Development Status of Novartis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

  • Figure Sales and Growth Rate Analysis of Novartis

  • Figure Revenue and Market Share Analysis of Novartis

  • Table Product and Service Introduction of Novartis

  • Table Company Profile and Development Status of Cellectis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellectis

  • Figure Sales and Growth Rate Analysis of Cellectis

  • Figure Revenue and Market Share Analysis of Cellectis

  • Table Product and Service Introduction of Cellectis

  • Table Company Profile and Development Status of Adaptimmune

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adaptimmune

  • Figure Sales and Growth Rate Analysis of Adaptimmune

  • Figure Revenue and Market Share Analysis of Adaptimmune

  • Table Product and Service Introduction of Adaptimmune


Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top